The Board of Directors
Mr Simon O’Loughlin, Chairman
 |
|
Corporate and commercial solicitor with
extensive experience in the formation, structuring and listing of small to
medium enterprises. Mr O'Loughlin is based in Adelaide, Australia. |
Dr Paul Tan, Chief Executive Officer, Executive Director
 |
|
Dr Paul Tan was appointed Chief Executive Officer of Living Cell Technologies
on 24 January, 2007. Previously LCT Managing Director of NZ Operations, he has had wide experience on
all aspects of assessment and selection of products for commercialization, expansion of intellectual
property, product development and managing critical paths, timelines and establishing and managing
international partnerships. Dr Tan is a member of the Management Committee of the Auckland branch of NZBio,
and sits on the Ministry of Health Interim Expert Committee for Xenotransplantation. |
Mr David Collinson, Founding Director
 |
|
Experienced in government manufacturing advocacy,
business management and capital raising, Mr Collinson co-founded LCT in
1987 and is based in New Zealand. |
Professor Robert Elliott, Medical Director
 |
|
A world leader in diabetes and
autoimmune related research, Professor Elliott co-founded
LCT in 1987. He was Foundation Professor, Department of Paediatrics
at the University of Auckland and is an Emeritus Professor of child health research. |
Dr Robert Caspari, Independent Director
 |
|
Dr. Caspari is a physician with extensive experience in the pharmaceutical and biotechnology industries. He has led clinical groups at international pharmaceutical companies and has worked in product manager and medical affairs roles.
Dr. Caspari has also had significant clinical experience with diabetes.
More recently, Dr. Caspari has held senior positions at US-based biotechnology companies. He was Senior Vice President of Commercial Operations at Myogen Inc., and is currently President and CEO of Aurogen Inc., a drug development company focused on neurological disorders. |
Dr David Brookes, Independent Director
Dr Brookes has received a Bachelor of Medicine and Bachelor of
Surgery at
Adelaide University and is a Fellow of the Australian College of Rural and Remote Medicine. He currently
works as a general medical practitioner and has extensive experience in rural Australia, especially in
paediatric and procedural practice. His involvement in the biotechnology sector started in the mid 1990's,
as an analyst for broking firm Taylor Collison Ltd.
He is also currently Chairman of Innovance Ltd (listed on the Newcastle stock exchange). |
Mr Laurie Hunter, Independent Director
Based in San Francisco, Mr Hunter founded
Hunter Capital LLC which provides corporate and financial services
to developing companies. He brings significant experience in financial
and commercial matters to
the Board. |
Mr Nicholas Geddes, Company Secretary
| Mr Geddes is a member of the National Council
of Chartered Secretaries Australia. His previous experience as a Chartered
Accountant and Company Secretary includes investment banking, development
and venture capital in Europe, Africa, the Middle East and Asia. |
|
